Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Longitudinal molecular trajectories of diffuse glioma in adults.

Autor: Barthel FP; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Pathology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Johnson KC; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Varn FS; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Moskalik AD; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Tanner G; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Kocakavuk E; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; DKFZ Division of Translational Neurooncology at the West German Cancer Center, German Cancer Consortium Partner Site, University Hospital Essen, Essen, Germany.; Department of Neurosurgery, University Hospital Essen, Essen, Germany., Anderson KJ; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Abiola O; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Alfaro KD; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alpar D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Amin SB; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Ashley DM; Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, USA., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Cambridge, MA, USA., Barnholtz-Sloan JS; Department of Population and Quantitative Health Sciences, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Beroukhim R; Broad Institute, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Brastianos PK; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Brat DJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Brodbelt AR; Department of Neurosurgery, University of Liverpool & Walton Centre NHS Trust, Liverpool, UK., Bruns AF; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Bulsara KR; Division of Neurosurgery, The University of Connecticut Health Center, Farmington, CT, USA., Chakrabarty A; Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK., Chakravarti A; Department of Radiation Oncology, The Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital, Columbus, OH, USA., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT, USA., Claus EB; Yale University School of Public Health, New Haven, CT, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Cochran EJ; Department of Pathology & Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Connelly J; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA., Costello JF; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Finocchiaro G; Fondazione IRCCS Istituto Neurologico Besta, Milano, Italy., Fletcher MN; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., French PJ; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Gan HK; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Gilbert MR; Neuro-Oncology Branch, National Institutes of Health, Bethesda, MD, USA., Gould PV; Anatomic Pathology Service, Hôpital de l'Enfant-Jésus, CHU de Québec-Université Laval, Quebec, Quebec, Canada., Grimmer MR; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Iavarone A; Department of Neurology, Columbia University Medical Center, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA., Ismail A; Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK., Jenkinson MD; Department of Neurosurgery, University of Liverpool & Walton Centre NHS Trust, Liverpool, UK., Khasraw M; Cooperative Trials Group for Neuro-Oncology (COGNO) NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Kim H; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Kouwenhoven MCM; Department of Neurology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., LaViolette PS; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA., Li M; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Lichter P; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ligon KL; Broad Institute, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Lowman AK; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA., Malta TM; Department of Neurosurgery, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Mazor T; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., McDonald KL; Cure Brain Cancer Biomarkers and Translational Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Molinaro AM; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Nam DH; Department of Neurosurgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, South Korea., Nayyar N; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Ng HK; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong., Ngan CY; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Niclou SP; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Niers JM; Department of Neurology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Noushmehr H; Department of Neurosurgery, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Noorbakhsh J; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Ormond DR; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA., Park CK; Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea., Poisson LM; Department of Public Health Sciences, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Rabadan R; Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.; Department of Systems Biology, Columbia University, New York, NY, USA., Radlwimmer B; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rao G; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reifenberger G; Institute of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Sa JK; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, South Korea., Schuster M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Shaw BL; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Short SC; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Smitt PAS; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Sloan AE; Department of Neurological Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.; Department of Neurosurgery, Case Western Reserve University, Cleveland, OH, USA.; Seidman Cancer Center and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Suzuki H; The Hospital for Sick Children, Toronto, ON, Canada., Tabatabai G; Interdiscplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, DKTK Partner Site Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Van Meir EG; Department of Neurosurgery, School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, USA., Watts C; Institute of Cancer Genome Sciences, Department of Neurosurgery, University of Birmingham, Birmingham, UK., Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Wesseling P; Department of Pathology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Westerman BA; Department of Neurosurgery, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Widhalm G; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Woehrer A; Institute of Neurology, Medical University of Vienna, Vienna, Austria., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zadeh G; Division of Neurosurgery, Department of Surgery, University Health Network, Toronto, Ontario, Canada., Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., De Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stead LF; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Verhaak RGW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. roel.verhaak@jax.org.

Publikováno v: Nature [Nature] 2019 Dec; Vol. 576 (7785), pp. 112-120. Date of Electronic Publication: 2019 Nov 20.